CiNZ

Improving human health outcomes one transition state analogue at a time

The Ferrier Research Institute and Albert Einstein College of Medicine have spent three decades fine-tuning the process of Transition state (TS) analogue design. This article aims to provide a high-level introduction to the process, and provide selected examples that highlight the relevance of this process to drug development.

Amy J. Foster, Farah Lamiable-Oulaïdi and Peter C. Tyler

The views and opinions expressed in Chemistry inNew Zealand are those of the individual authors and are not necessarily those of the publisher, the Editorial Board or the New Zealand Institute of Chemistry.
Whilst the publisher has taken every precaution to ensure the total accuracy of material contained in Chemistry in New Zealand, no responsibility for errors or omissions will be accepted.

All material published is licensed under a CC-BY-NC-ND 4.0 license, see more

small-molecule drugs

Improving human health outcomes one transition state analogue at a time

Subscribe to the CINZ newsletter